TRANSFORMING GROWTH FACTOR β1 AND SOLUBLE FAS SERUM LEVELS IN HEPATOCELLULAR CARCINOMA

By Sacco R.   Leuci D.   Tortorella C.   Fiore G.   Marinosci F.   Antonaci S.  

Cytokine, Vol. 12, Iss. 6, 2000-06 ,pp. : 811-814

Academic Press

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma

By Gershtein E.   Dubova E.   Shchegolev A.   Kushkinskii N.  

Bulletin of Experimental Biology and Medicine, Vol. 149, Iss. 6, 2010-11 ,pp. : 749-752

Springer Publishing Company

Access to resources Recommend Favorite

Skeletal Unloading Induces Biphasic Changes in Insulin-Like Growth Factor-I mRNA Levels and Osteoblast Activity

By Drissi H.   Lomri A.   Lasmoles F.   Holy X.   Zerath E.   Marie P.J.  

Experimental Cell Research, Vol. 251, Iss. 2, 1999-09 ,pp. : 275-284

Elsevier

Access to resources Recommend Favorite

High Expression of Met/Hepatocyte Growth Factor Receptor Suppresses Tumorigenicity in NCI-H1264 Lung Carcinoma Cells

By To C.   Seiden I.   Liu N.   Wigle D.   Tsao M.-S.  

Experimental Cell Research, Vol. 273, Iss. 1, 2002-02 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

SERUM TUMOUR NECROSIS FACTOR-α AND TRANSFORMING GROWTH FACTOR-β LEVELS IN CHRONIC HEPATITIS C PATIENTS ARE IMMUNOMODULATED BY THERAPY

By Neuman M.G.   Benhamou J-P.   Bourliere M.   Ibrahim A.   Malkiewicz I.   Asselah T.   Martinot-Peignoux M.   Shear N.H.   Katz G.G.   Akremi R.   Benali S.   Boyer N.   Lecomte L.   Le Breton V.   Le Guludec G.   Marcellin P.  

Cytokine, Vol. 17, Iss. 2, 2002-01 ,pp. : 108-117

Academic Press

Access to resources Recommend Favorite